Gutiérrez Aguirre, C. H., Cantú Rodríguez, O. G., Borjas Almaguer, O. D., González Llano, Ó., Jaime Pérez, J. C., Solano Genesta, M., . . . Gómez Almaguer, D. (2012). Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease.
Cita Chicago Style (17a ed.)Gutiérrez Aguirre, César Homero, et al. Effectiveness of Subcutaneous Low-dose Alemtuzumab and Rituximab Combination Therapy for Steroid-resistant Chronic Graft-versus-host Disease. 2012.
Cita MLA (9a ed.)Gutiérrez Aguirre, César Homero, et al. Effectiveness of Subcutaneous Low-dose Alemtuzumab and Rituximab Combination Therapy for Steroid-resistant Chronic Graft-versus-host Disease. 2012.
Precaución: Estas citas no son 100% exactas.